ArticleOncology reports2021
[Corrigendum] Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis.
Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
- Erratum for
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of this article, an interested reader contacted the authors about some possible anomalies in the presentation of the data in Table I, and they have realized that this Table contained some errors. Two different entries for the miRNA hsa‑miR‑886‑3p were inadvertently included in the Table, due to there being two different microarray IDs for this miRNA when performing differential analysis by GEO2R (Owing to an oversight, the repeated miRNA was not deleted; therefore, the row of data for the second has‑miR‑886‑3p entry, comprising P‑value 0.00235, t‑value, 3.82, B‑value, ‑4.58 and logFC, 3.2 has been deleted, and the correct data row for the miRNA hsa‑miR‑513a‑5p has been inserted.) A corrected version of the Table is shown opposite (the corrected data row entry is highlighted in bold). The authors sincerely apologize for the errors that were introduced during the preparation of this Table, and thank the reader of their article who drew this matter to their attention. Furthermore, they regret any inconvenience that this mistake has caused. [the original article was published in Oncology Reports 42: 533‑548, 2019; DOI: /10.3892/or.2019.7173].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.